Laboratory News and Research

RSS

Combination therapy effective in treating drug-resistant malaria

Resistance to artemisinin, the main drug to treat malaria, is now widespread throughout Southeast Asia, among the Plasmodium falciparum (P. falciparum) parasites that cause the disease and is likely caused by a genetic mutation in the parasites.

31 Jul 2014

New research may provide better treatment options for children with cerebral palsy

Of cerebral palsy, caregivers and patients know this is an understatement: it's not easy. The permanently debilitating condition, which occurs in babies from the prenatal stage to toddlers, comes with more than its fair share of lifelong challenges - from mobility problems to developmental setbacks.

31 Jul 2014

Statin therapy may speed up wound healing following cardiac surgery

Statin therapy may help to improve wound healing in patients following cardiac surgery and reduce overall recovery time, especially in patients who are prone to healing complications, according to a review article in the August 2014 issue of The Annals of Thoracic Surgery.

31 Jul 2014

Researchers discover new vaccine targets to combat malaria

Researchers have discovered new vaccine targets that could help in the battle against malaria. Taking a new, large-scale approach to this search, researchers tested a library of proteins from the Plasmodium falciparum parasite with antibodies produced by the immune systems of a group of infected children.

31 Jul 2014

Researchers discover new function of body's most important tumor-suppressing protein

Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered a new function of the body's most important tumor-suppressing protein. Called p53, this protein has been called "the guardian of the genome."

30 Jul 2014

New anesthesia procedure demonstrates cause of obstruction in patients with severe sleep apnea

A simplified anesthesia procedure may enable more widespread use of preoperative testing to demonstrate the cause of airway obstruction in patients with severe sleep apnea, suggests a study in Anesthesia & Analgesia.

30 Jul 2014

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013.

From Quest Diagnostics 29 Jul 2014

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

Researchers identify porcine enterovirus G using next-generation sequencing

He calls himself the bug hunter, but the target of his work consists of viruses that can only be found and identified with special methods and instruments.

29 Jul 2014

Researcher examines how motivated older adults maintain focus on cognitive tasks

A psychology researcher at North Carolina State University is proposing a new theory to explain why older adults show declining cognitive ability with age, but don't necessarily show declines in the workplace or daily life.

29 Jul 2014

Little-known supportive cells in brain may play major role in cognitive function

When you're expecting something-like the meal you've ordered at a restaurant-or when something captures your interest, unique electrical rhythms sweep through your brain.

29 Jul 2014

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

About 100 drugs already approved by the U.S. Food and Drug Administration (FDA) for other purposes can also prevent the growth of certain bacterial pathogens inside human cells, including those that cause Legionnaires' disease, brucellosis, and Mediterranean spotted fever.

29 Jul 2014

Cancer researchers find molecule that irreversibly interferes with KRAS gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

A new in vitro study has revealed that nicotine and cotinine, a metabolite of nicotine, can potentially inhibit DNA damage caused by a certain carcinogen in smoke.

28 Jul 2014

Antifungal drug resistance evoked through RNAi-dependent epimutations

Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs.

27 Jul 2014

AACC unveils updated brand identity

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, unveiled an updated brand identity today that reflects the organization's commitment to help laboratory professionals adapt to the changing healthcare environment and continue to do what they do best: provide vital insight to physicians, so patients get the care they need.

27 Jul 2014

Timely diagnosis and treatment important to combat juvenile arthritis

Most people associate arthritis with aging, but the fact is, one in 1,000 children is diagnosed with juvenile arthritis.

27 Jul 2014

Xybion to host first annual Global User Group Conference in Philadelphia, Pennsylvania

Xybion Corporation, the leading provider of software, services and consulting for global corporations operating in highly regulated industries, announced today that the company will host its first annual Global User Group Conference, Xybion International Exchange, on October 21-23, 2014 in historic Philadelphia, Pennsylvania at the Sheraton Society Hill Hotel.

26 Jul 2014

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.

26 Jul 2014

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil.

26 Jul 2014

Laboratory News and Research

Combination therapy effective in treating drug-resistant malaria

New research may provide better treatment options for children with cerebral palsy

Statin therapy may speed up wound healing following cardiac surgery

Researchers discover new vaccine targets to combat malaria

Researchers discover new function of body's most important tumor-suppressing protein

New anesthesia procedure demonstrates cause of obstruction in patients with severe sleep apnea

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

Researchers identify porcine enterovirus G using next-generation sequencing

Researcher examines how motivated older adults maintain focus on cognitive tasks

Little-known supportive cells in brain may play major role in cognitive function

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

Cancer researchers find molecule that irreversibly interferes with KRAS gene

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

Antifungal drug resistance evoked through RNAi-dependent epimutations

AACC unveils updated brand identity

Timely diagnosis and treatment important to combat juvenile arthritis

Xybion to host first annual Global User Group Conference in Philadelphia, Pennsylvania

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics